United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read General business news ASX top losers on April 16, 2025: Market turbulence and sectoral challenges deepen investor concerns ASX top losers on April 16, 2025, saw sharp declines across sectors—from lithium and biotech to telecom—amid rising economic and industry-specific concerns. byPallavi MadhirajuApril 16, 2025